LG Chem acquires approval of diabetes & dyslipidemia complex for first time in Korea

LG Chem announced ‘Zemiro,’ a complex drug developed for 5 years as a treatment of diabetes and dyslipidemia, was approved to be commercialized in Korea from the Ministry of Food and Drug Safety. It is the first time for a complex drug of diabetes and dyslipidemia to acquire commercialization approval in Korea. 

LG Chem’s ‘Zemiro’ is an incrementally modified drug which combined ‘Zemiglo(gener...